Skip to main content

Understanding Idiopathic Pulmonary Fibrosis: New Insights and Emerging Treatment Options

  • 2,326

    Total downloads

  • 14k

    Total views and downloads

About this Research Topic

This Research Topic is closed for submissions.

Background

Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, and often fatal lung disease characterized by the scarring (fibrosis) of lung tissue, resulting in a gradual decline in lung function.
Despite advancements in medical research, the precise etiology of IPF remains poorly understood, posing significant challenges to timely diagnosis and effective treatment. The complexity of IPF underscores the urgent need for a comprehensive exploration of its underlying molecular mechanisms and the development of innovative therapeutic strategies.

Recent advancements in the field have provided critical insights into genetic predisposition, environmental triggers, and molecular pathways implicated in the development and progression of IPF. Current treatment options, including antifibrotic drugs such as pirfenidone and nintedanib, can decelerate disease progression but are not curative, leaving an unmet need for therapies that can halt or reverse fibrosis. Moreover, there is a growing recognition of the importance of identifying biomarkers for early detection and personalized treatment.

This proposal aims to report the latest research findings and explore emerging treatment strategies for Idiopathic Pulmonary Fibrosis. Collaboration between researchers, clinicians, and industry experts will enhance our understanding of IPF and accelerate the development of more effective therapeutic options by:

Investigating Novel Biomarkers in IPF Pathobiology:
- Identify and validate biomarkers for early diagnosis, disease monitoring, and prognostic assessment.
- Explore biomarkers that predict response to treatment, enabling personalized therapeutic approaches.

Evaluating Current Treatments, its Impact, and Outcomes in IPF Patients:
- Assess the clinical efficacy, safety, and patient-reported outcomes of existing antifibrotic therapies.
- Identify limitations and gaps in current treatment paradigms.

Exploring Emerging Therapies in IPF Pathogenesis:
- Investigate innovative therapeutic approaches targeting specific molecular pathways involved in fibrosis.
- Assess the potential of combination therapies to enhance treatment efficacy.

Examining Molecular Mechanisms Driving IPF Progression:
- Elucidate key molecular and cellular mechanisms driving fibrosis.
- Investigate the role of epithelial-mesenchymal transition, extracellular matrix remodeling, and immune dysregulation in IPF pathogenesis.

Evaluating Novel Antifibrotic Agents as Therapeutics:
- Explore the development and preclinical/clinical evaluation of novel antifibrotic drugs.
- Assess the potential for repurposing existing drugs to target fibrotic pathways.

Investigating Regenerative Medicine Approaches for IPF Treatment:
- Explore the role of regenerative medicine approaches, including stem cell therapies, in repairing lung tissue.
- Evaluate the feasibility and efficacy of tissue engineering and other emerging techniques.

Identifying Future Directions in IPF Research and Treatment:
- Highlight gaps in current research and propose new avenues for investigation.
- Promote interdisciplinary collaborations to advance IPF research and treatment.

Prof. Cecilia Prele's research is funded by NHMRC and MRFF Australia, collaborates with Biotome Pty Ltd and MeDEL, and serves as a board member for the Thoracic Society of Australia and New Zealand (TSANZ).

Research Topic Research topic image

Keywords: Idiopathic Pulmonary Fibrosis, lung disease, biomarkers, emerging therapies, IPF management

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic editors

Impact

  • 14kTopic views
  • 8,522Article views
  • 2,326Article downloads
View impact